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Modeling the Effect of APC Truncation on Destruction
Complex Function in Colorectal Cancer Cells
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Abstract
In colorectal cancer cells, APC, a tumor suppressor protein, is commonly expressed in truncated form. Truncation of APC is
believed to disrupt degradation of b—catenin, which is regulated by a multiprotein complex called the destruction
complex. The destruction complex comprises APC, Axin, b—catenin, serine/threonine kinases, and other proteins. The
kinases CK1a and GSK{3b, which are recruited by Axin, mediate phosphorylation of b—catenin, which initiates its
ubiquitination and proteosomal degradation. The mechanism of regulation of b—catenin degradation by the destruction
complex and the role of truncation of APC in colorectal cancer are not entirely understood. Through formulation and
analysis of a rule-based computational model, we investigated the regulation of b—catenin phosphorylation and
degradation by APC and the effect of APC truncation on function of the destruction complex. The model integrates
available mechanistic knowledge about site-specific interactions and phosphorylation of destruction complex components
and is consistent with an array of published data. We find that the phosphorylated truncated form of APC can outcompete
Axin for binding to b—catenin, provided that Axin is limiting, and thereby sequester b—catenin away from Axin and the
Axin-recruited kinases CK1a and GSK{3b. Full-length APC also competes with Axin for binding to b—catenin; however,
full-length APC is able, through its SAMP repeats, which bind Axin and which are missing in truncated oncogenic forms of
APC, to bring b—catenin into indirect association with Axin and Axin-recruited kinases. Because our model indicates that
the positive effects of truncated APC on b—catenin levels depend on phosphorylation of APC, at the first 20-amino acid
repeat, and because phosphorylation of this site is mediated by CK1E, we suggest that CK1E is a potential target for
therapeutic intervention in colorectal cancer. Specific inhibition of CK1E is predicted to limit binding of b—catenin to
truncated APC and thereby to reverse the effect of APC truncation.
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and two scaffold proteins, Axin (axis inhibition protein, AXIN1)
and APC (adenomatous polyposis coli protein), mediates phosphorylation of b{catenin by recruiting GSK{3b (glycogen
synthetase kinase{3b, GSK3B) and CK1a (casein kinase Ia,
CSNK1A1) [11–15]. These kinases, upon binding Axin, catalyze
phosphorylation of b{catenin on specific serine and threonine
residues. Phosphorylation of Ser-45 by CK1a and subsequent
phosphorylation of Ser-33, Ser-37, and Thr-41 by GSK{3b
initiates ubiquitination and proteosome-mediated degradation of
b{catenin [12–15]. The destruction complex also recruits PP2A,
a multimeric protein phosphatase, which opposes the action of
kinases. It has been suggested that activation of Wnt/b{catenin
signaling destabilizes the destruction complex by sequestering Axin
in complexes with activated Fz receptors [16–18]. However,
details about the early events in Wnt/b{catenin signaling are still
emerging [19,20]. In colorectal cancer cells, the destruction
complex member APC is often truncated [21]. An important effect
of APC truncation is believed to be a perturbation of the
interactions amongst proteins comprising the destruction complex

Introduction
b{catenin (CTNNB1) is a key signaling protein in the
Wnt=b{catenin pathway [1,2], a regulator of cadherin cell
adhesion molecules [3], and a regulator of the Tcf and Lef family
of transcription factors [4–7]. In mesenchymal cells, b{catenin
levels increase when a Wnt ligand binds a cell-surface Frizzled
(Fz)-family receptor. Activation of the Wnt/b{catenin pathway
(transiently) inhibits proteosome-mediated degradation of
b{catenin. Wnt binding also has other important effects on
b{catenin, including regulation of phosphorylation state and
redistribution of b{catenin within subcellular compartments. In
colorectal cancer cells, normal control of b{catenin degradation
is disrupted, resulting in elevated levels of b{catenin.
Cellular degradation of b{catenin is regulated by (in our view)
oligomeric protein complexes, which have diverse compositions
but common features; these complexes are often collectively
referred to as the b{catenin destruction complex [8–10]. The
destruction complex, which characteristically contains b{catenin
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phosphorylated, mediates interaction with a site in b{catenin
that also interacts with Axin [22–25]. Thus, phosphorylated APC
and Axin compete for binding to b{catenin. The outcome of this
competition is perhaps dependent on stability of the destruction
complex.
Much of what we know about the functional effects of APC
truncation has come from studies of a human colon adenocarcinoma cell line (SW480). SW480 cells express a truncated form of
APC termed APC1338, which contains only the first 1,338 amino
acids of the full-length protein [9,31]. APC1338 contains all three
15-aa repeats and the first 20-aa repeat, but is devoid of the
remaining six 20-aa repeats and the SAMP repeats, which bind
Axin [9,31]. Therefore, a model can be conceptualized wherein
assembly of the functional destruction complex cannot be
completed in the absence of interaction between APC1338 and
Axin, leading to decreased phosphorylation, ubiquitination, and
degradation of b{catenin [2]. However, an absence of SAMP
repeats in APC does not prevent direct binding of Axin to
b{catenin [22,23], and there are some uncertainties about the
validity of this model [19] because reports from different
laboratories have shown that expression of recombinant APC
can either promote degradation of b{catenin or have no or little
effect, depending on cell type and whether APC is expressed
transiently or stably [31–34].
As discussed above, APC plays an important role in destruction
complex function. However, APC is a multifunctional protein,
subject to numerous post-translational modifications. It is believed
to play a role in regulating not only phosphorylation and
ubiquitination of b{catenin but also localization of b{catenin.
There are several pools of b{catenin: membrane-associated (e.g.,
complexed with E-cadherin), cytosolic (free, a{catenin bound
and Tcf bound), and nuclear. Other components of the
destruction complex are also multifunctional proteins, which can
be found in distinct subcellular locations and states. For example,
Axin, through self-polymerization mediated by its DIX (dishevelled and axin) domain [35], localizes to cytoplasmic puncta. We
will not consider these complexities, but they are mentioned at this
point to caution the reader about the limitations of our study.
Here, our focus will be on APC regulation of b{catenin
phosphorylation within an idealized destruction complex, taken to
comprise a ternary complex of APC, Axin, and b{catenin with
1:1:1 stoichiometry. We will consider the site-specific details of the
interactions amongst these proteins, because these details are
relevant for understanding how the interactions of APC, Axin, and
b{catenin are perturbed by an absence of SAMP repeats in
truncated APC (APC1338). We also consider, with less mechanistic resolution, proteins that mediate phosphorylation and dephosphorylation of APC and b{catenin and degradation of
b{catenin. The set of proteins of interest are considered in
isolation. Thus, for example, we do not consider b{catenin
interaction with E-cadherin, or the effects of Wnt. We also do not
consider Axin puncta or the DIX domain in Axin. Axin puncta
play a role in b{catenin degradation but are not required for
phosphorylation of b{catenin [36].
To investigate the roles of APC and its oncogenic truncated
forms in destruction complex function, we formulated a computational model for regulation of b{catenin phosphorylation and
degradation using local rules to represent the protein-protein
interactions of interest [37–39]. This rule-based approach, ideal
for modeling the chemical kinetics of biomolecular interaction
networks, allowed us to consider the mechanistic details of proteinprotein interactions at the resolution level of functional sites within
the proteins of interest. These mechanistic details are complex, as
summarized above, and arguably beyond our ability to compre-

Author Summary
We asked the question, how can the effects of APC
truncation, a very common mutation in colorectal cancer,
be understood and reversed? We addressed this question
by formulating a computational model for destruction
complex function that incorporates site-specific details
about protein-protein interactions and protein phosphorylation and examined the differences in predicted behaviors when APC is full length, as in normal cells, and
truncated, as in colorectal cancer cells. Our model offers an
explanation for how and why destruction complex
function is altered by APC truncation. The model indicates
that phosphorylation of the first 20-amino acid repeat in
APC (which is usually the only 20-amino acid repeat that
remains in truncated forms of APC) together with the
absence of SAMP repeats (missing entirely because of
truncation) allows truncated APC to act as a diversion sink.
In other words, phosphorylated APC can outcompete Axin
for binding to b{catenin, provided Axin is limiting, and
thereby prevent b{catenin from associating with Axin
and the Axin-associated kinases CK1a and GSK{3b,
which initiate phosphorylation-dependent degradation of
b{catenin. Thus, the model identifies inhibition of APC
phosphorylation, which is mediated by CK1E, as a
potential means by which the oncogenic effect of APC
truncation could be reversed.

that alters regulation of b{catenin degradation, perhaps by
destabilizing the destruction complex in a way similar to the
destabilization brought about by Wnt signaling.
The interactions responsible for assembly of the destruction
complex are complex and are mediated by multiple functional sites
within the member proteins of the destruction complex. The
characteristic core of the destruction complex can be viewed as a
ternary complex that forms through interactions of APC, Axin,
and b{catenin. b{catenin contains twelve ARM (Armadillo)
repeats, allowing it to bind both APC and Axin. In particular,
ARM repeats 3 and 4 constitutively bind a central region of Axin
[22,23] as well as a phosphorylated 20-amino acid (20-aa) repeat
region of APC [24,25]. There are total of seven 20-aa repeats in
this region. b{catenin ARM repeats 5–9 constitutively bind three
15-amino acid (15-aa) repeats in the N-terminal region of APC
[26]. APC contains three SAMP (serine-alanine-methionineproline) repeats, which bind the RGS (regulator of G protein
signaling) domain of Axin [27]. These interactions connect the
three core proteins of the destruction complex (APC, Axin, and
b{catenin) and enable each protein to bind the other two core
proteins, possibly within a closed/cyclic ternary complex. A cyclic
complex would presumably be highly stable, because dissociation
of such a complex would require the sequential break up of two
protein-protein interactions.
Stability of the destruction complex may be important for its
function as a platform for phosphorylation of b{catenin, and
other proteins. The destruction complex mediates phosphorylation
of b{catenin by allowing Axin to colocalize the kinases
GSK{3b and CK1a with their substrate b{catenin. Axin
contains binding sites for both GSK{3b [11,28] and CK1a
[12,29]. Interestingly, the destruction complex is also thought to
mediate phosphorylation of APC by colocalizing another kinase,
CK1E (CSNK1E), with APC [30], although it is not known which
protein in the destruction complex recruits CK1E. CK1E and
GSK{3b together mediate phosphorylation at the 20-aa repeat
region of APC [30]. Recall that this region in APC, when
PLOS Computational Biology | www.ploscompbiol.org
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based modeling framework of BioNetGen [37–39] (see Materials
and Methods). We considered a base model, corresponding to a
normal cell with full-length APC, and several variant forms of the
base model. The base model is illustrated in Figs. 1 and 2. The
model is annotated in Text S1 (Supporting Information).
Executable BioNetGen input files are provided in the Supporting
Information for the base model (Text S2) and eight variant forms
of the base model (Text S3 through Text S10).
In the base model, both explicit and implicit interactions are
considered. We explicitly consider the interactions of five signaling
proteins (and their isoforms presumed to be functionally equivalent): APC, Axin, b{catenin, CK1a, and GSK{3b. We
implicitly consider the interactions of CK1E, PP2A, other
phosphatases, and the proteins responsible for ubiquitination
and proteosomal degradation of b{catenin. In Fig. 2, proteins
and their interactions are represented with site-specific/structural
resolution using the conventions of Chylek et al. [42]. Briefly,
proteins and their functional components are represented by
nested boxes. Components excluded from consideration (e.g., the
DIX domain of Axin) are not illustrated in Fig. 2. Arrows
connecting boxes represent interactions. It should be noted that
the visual elements of Fig. 2 correspond to the formal elements of
our model [42]: boxes correspond to molecule types and arrows
correspond to rules for interactions (Text S1). Each interaction
included in the model is discussed below. The technical details of
how these interactions are modeled/represented using rules are
explained in Text S1. See also the Materials and Methods section.
Arrow 1 in Fig. 2 represents reversible binding of b{catenin
ARM repeats 5–9 to the 15-aa repeats of APC [22,26]. In the
model, ARM repeats 5–9 are considered to comprise a single
binding site. Likewise, the three 15-aa repeats in APC are
considered to comprise a single binding site.
Arrow 2 represents reversible binding of b{catenin ARM
repeats 3 and 4 to phosphorylated APC 20-aa repeats [22]. In the
model, ARM repeats 3 and 4 are considered to comprise a single
binding site. The seven 20-aa repeats of APC are taken to function
as two distinct binding sites, with binding activity of one site
considered to be mutually exclusive with binding activity of the
other site. The first site (labeled 1) corresponds to the first 20-aa
repeat and the second site (labeled 3) corresponds to the third 20aa repeat. We consider binding of APC to b{catenin to be
mediated by the phosphorylated first repeat when the protein is
APC1338 (or a comparable truncated form of APC), and
predominantly (exclusively in the model as a simplification) by
the phosphorylated third repeat if the protein is full-length APC.
This distinction is made because APC1338 contains only the first
20-aa repeat, whereas full-length APC contains all seven 20-aa
repeats. Binding of full-length APC to b{catenin is mediated
primarily by the phosphorylated third 20-aa repeat [25] because
the phosphorylated third repeat binds with 100- to 1000-fold
higher affinity than that of any of the other phosphorylated 20-aa
repeats [25]. We take the stoichiometry of a b{catenin-APC
complex to be 1:1.
Arrow 3 represents reversible binding of b{catenin to Axin.
ARM repeats 3 and 4 of b{catenin bind a central region of Axin
[22,23]. As noted before, ARM repeats 3 and 4 also bind the
phosphorylated 20-aa repeat region of APC (Arrow 2). Thus,
ARM repeats 3 and 4 represent a b{catenin binding site
recognized by both APC and Axin.
Arrow 4 represents reversible binding of APC to Axin. The
three SAMP repeats of APC bind the RGS domain of Axin
[27,43]. In the model, as a simplification, the SAMP repeats are
considered to comprise a single binding site. Thus, we take the
stoichiometry of an APC-Axin complex to be 1:1.

hend without reasoning aids, such the model considered here.
Using this model, we interrogated system behavior, which emerges
from the states and state changes of protein sites, with the goal of
elucidating the distinctive mechanisms by which APC and
APC1338 regulate the rate of b{catenin destruction in normal
and SW480 colorectal cancer cells. We also used our model to
investigate the functional significance of intracomplex interactions
among APC, Axin, and b{catenin, which have the potential to
produce a highly stable cyclic ternary complex.
Although APC is a characteristic component of the destruction
complex and thought to be important for degradation of
b{catenin [31–34], our analyses suggest that APC does not
promote degradation of b{catenin in a normal cell when
overexpressed. However, we do predict that expression of
recombinant full-length APC in SW480 cells promotes
b{catenin degradation, as seen in several studies [31–34].
These results are obtained because, according to our model,
phosphorylated APC1338 in SW480 cells competes with Axin
for b{catenin. APC1338-mediated separation of b{catenin
from Axin reduces phosphorylation of b{catenin by Axinrecruited kinases, and reduced phosphorylation of b{catenin
decreases its rate of degradation. In contrast, in normal cells,
binding of phosphorylated full-length APC to b{catenin, in
competition with Axin, is not functionally equivalent because
Axin can still colocalize with b{catenin through indirect
association via the SAMP repeats in APC, which are missing in
APC1338. Because of these results and because CK1E is
responsible for phosphorylation of APC (but not b{catenin),
we identify CK1E as a potential target for therapeutic
intervention in colorectal cancer. Inhibition of CK1E is
predicted to limit sequestration of b{catenin away from Axin
and Axin-associated kinases and thereby to lower b{catenin
levels in cancer cells expressing truncated APC.

Results
To investigate how the function of the b{catenin destruction
complex changes when APC is mutated, especially as a result of a
typical C-terminal truncation that removes the SAMP repeats and
all but the first of the 20-aa repeats, we formulated a model (as
described below) for full-length APC interactions with other
components of the destruction complex. We then used this model
and variants corresponding to different mutated forms of APC to
predict how b{catenin levels and other readouts of system
behavior depend on various parameters, such as the abundance of
APC or truncated APC. Because APC contains multiple functional
components or sites and we are interested in forms of APC
containing different subsets of these sites, we formulated a model
that tracks the chemical kinetics of the protein-protein interactions
of interest with site-specific/structural resolution. This was
accomplished by leveraging the rule-based modeling approach
[37,40], in which local rules are used to represent biomolecular
interactions and their consequences. Modeling with site-specific
resolution is difficult with traditional modeling approaches, such as
that of ordinary differential equations (ODEs), because of
combinatorial complexity [41], which arises from multisite
phosphorylation, multivalent binding, and other common aspects
of biomolecular interactions involved in cellular regulation.
Combinatorial complexity is a motivating factor for the use of
rule-based modeling here.

Model
We developed a model for APC, Axin, and b{catenin
interactions and destruction complex function using the rulePLOS Computational Biology | www.ploscompbiol.org
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Figure 1. Overview of the signaling proteins and interactions considered in the model. Panel A is a simplified version of Fig. 2, which
follows and goes beyond the diagram shown here by illustrating the functional components of proteins responsible for interactions. Selected protein
complexes considered in the model are illustrated in Panels B–D. (A) Proteins are represented by boxes. In the model, five proteins, b{catenin, APC,
Axin, GSK{3b, and CK1a, are considered explicitly, whereas CK1E, PP2A (not shown), and other proteins are considered implicitly. CK1E, which
mediates phosphorylation of APC, and PP2A, which mediates dephosphorylation of APC, are assumed to be constitutively associated with Axin. In the
model, their activities are engaged when Axin is in complex with APC. Interactions included in the model are represented by arrows; numbering of
arrows is the same as in Fig. 2. The arrows labeled 1–6 represent reversible direct binding interactions. The arrows labeled 7–10 represent catalytic
(phosphorylation) interactions (and enzyme-substrate relationships). All phosphorylation events are taken to be reversed by phosphatases. The
interaction represented by Arrow 1 is constitutive. The interaction represented by Arrow 2 depends on sequential phosphorylation of APC by CK1E
and GSK{3b (Arrows 9 and 10). The interactions represented by Arrows 2 and 3 are mutually exclusive, because they involve the same binding site
in b{catenin, i.e., Axin and APC compete for binding to this site. The interaction between APC and Axin represented by Arrow 4 is missing for typical
truncated forms of APC (i.e., forms of APC, such as APC1338, missing SAMP repeats). Arrows 5 and 6 represent recruitment of GSK{3b and CK1a to
Axin. Arrows 7–10 represent phosphorylation reactions mediated by Axin-associated kinases. (B) A binary complex of APC and b{catenin connected
through two distinct protein-protein interfaces. The interactions represented by Arrows 1 and 2 are allowed to occur simultaneously. (C) A complex
wherein b{catenin is directly bound to Axin via the interaction represented by Arrow 3. Recall that this interaction cannot occur if b{catenin is
bound to APC via the interaction represented by Arrow 2. (D) A complex containing a linear (vs. cyclic) ternary complex of APC, Axin, and b{catenin.
This linear complex is allowed to close and form a cyclic complex via the interaction represented by Arrow 3. Note that the complex depicted here
cannot form when APC is truncated such that the interaction represented by Arrow 4 is missing. The model is further described in Fig. 2 and Text S1.
doi:10.1371/journal.pcbi.1003217.g001

we implicitly consider CK1E because it is not known which protein
is responsible for colocalizing CK1E with APC. Phosphorylation of
APC is taken to occur through a process with first-order kinetics
when APC and GSK{3b are colocalized via Axin. Thus, we
assume that CK1E is colocalized with APC in proportion to the
extent to which GSK{3b is colocalized with APC via Axin. This
assumption is equivalent to assuming that CK1E associates noncompetitively with Axin (or directly with GSK{3b).
We model dephosphorylation reactions as first-order processes
(without explicit consideration of phosphatases). We allow
dephosphorylation to occur if a site is exposed, i.e., not occupied
and shielded by a binding partner. In the model, both
phosphorylation sites of b{catenin (i.e., S45 and S33/S37) are
dephosphorylated according to the same rate law. In other words,
the same first-order dephosphorylation rate constant is used for
both sites. We allow the 20-aa repeats in APC to be dephosphorylated only if APC is in complex with Axin because Axin recruits
PP2A, a phosphatase that mediates dephosphorylation of APC
[46].
An important feature of the model is intracomplex binding of
APC, Axin, and b{catenin. In Fig. 2, Arrows 1–4 each represents
two distinct types of binding reactions: intermolecular binding,
and intracomplex binding. The former type of binding reaction
occurs when the reacting sites are freely diffusing, i.e., not
tethered. The latter type of binding reaction occurs when the
reacting sites are already in a complex together, i.e., tethered and

Arrows 5 and 6 represent reversible binding of GSK{3b and
CK1a to Axin, respectively. GSK{3b binds the GSK3 interaction domain (GID) of Axin [11,28,44]. CK1a binds a central
region of Axin [29], which is distinct from the binding sites in Axin
recognized by other binding partners. In the model, the binding of
CK1a, b{catenin and GSK{3b to Axin is taken to be noncompetitive and non-cooperative.
Arrows 7 and 8 represent phosphorylation of b{catenin by
Axin-bound CK1a and GSK{3b, respectively. b{catenin
phosphorylation takes place in a processive manner [12,13].
CK1a first phosphorylates Ser-45 (labeled as S45 in Fig. 1), and
GSK{3b then phosphorylates Ser-33, Ser-37, and Thr-41. In the
model, as a simplification, the latter three sites are lumped
together (labeled as S33/S37 in Fig. 2). We model the
phosphorylation reactions as processes with first-order kinetics
that occur only when kinases and substrates are colocalized within
a complex. In the model, phosphorylation at S45 occurs when
b{catenin is colocalized with Axin-associated CK1a. Phosphorylation at S33/S37 occurs when b{catenin is phosphorylated at
S45 and colocalized with Axin-associated GSK{3b [12,13]. We
do not consider phosphorylation of b{catenin outside the context
of the destruction complex.
Arrows 9 and 10 represent phosphorylation of APC 20-aa
repeats by CK1E and GSK{3b [30,45]. Both CK1E and
GSK{3b are required for phosphorylation of APC [30]. In
Fig. 2, CK1E is shown for illustration purposes only. In the model,
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interaction between b{catenin ARM repeats 3 and 4 and APC
20-aa repeats (Arrow 1) and interaction between b{catenin
ARM repeats 5–9 and APC 15-aa repeats (Arrow 2). The
intracomplex reactions between APC and b{catenin are allowed
to occur outside the context of a completely assembled destruction
complex.
In the model, except for b{catenin, the total concentrations of
signaling proteins are taken to be conserved (i.e., constant).
b{catenin is produced in a process with zeroth-order kinetics and
degraded in either a slow or fast process with first-order kinetics.
When S33/S37 is not phosphorylated, b{catenin is degraded at
a slow rate, regardless of its bound state. When S33/S37 is
phosphorylated, b{catenin is degraded at a fast rate, again
regardless of its bound state. Thus, we allow b{catenin to be
degraded, through a slow or fast process, independently of whether
it is free or bound. We assume that b{catenin releases any
binding partner(s) upon degradation.
The model has 27 independent parameters, including five
protein concentrations and 14 binding constants (Table 1).
Parameter values were specified as described in Materials and
Methods. A local sensitivity analysis indicates that model behavior
is not particularly sensitive to any individual parameter value
(Table S1).

Effects of APC mutation on b–catenin expression
Using the estimated parameter values summarized in Table 1
(see Materials and Methods), which were selected in part to allow
the model to reproduce certain system behaviors (Figs. S1 and S2),
we tested whether the model is able to predict the effects of
transfection of SW480 cells with different truncated forms of APC.
Munemitsu et al. [31] systematically transfected SW480 cells with
various forms of APC. These experiments were designed to
understand the effects of deletion of different functional components of APC on b{catenin levels in SW480 cells, which almost
exclusively express APC1338 instead of the full-length protein
[31,48].
Munemitsu et al. [31] transfected SW480 cells with full-length
APC or one of 11 different truncated forms of APC (illustrated in
Fig. 3). In our model, full-length APC and the 11 truncated forms
of the protein can be grouped into six distinctive classes, Classes
A–F (Fig. 3). The proteins in each class are functionally equivalent
based on the components and interactions of APC included in the
model (Fig. 2). For example, Munemitsu et al. [31] considered
three forms of APC each containing the following components: 1)
a partial or complete set of the 15-aa repeats, 2) all of the 20-aa
repeats, and 3) the SAMP repeats of APC. These are the
functional sites that we consider to be included in full-length APC
(Fig. 2). Therefore, we will use APC-A to represent all three
proteins, as we take these forms of APC to be functionally
equivalent. Similarly, we will use APC-B to represent two other
proteins, which both contain the 15-aa repeats and only the first
20-aa repeat. We take these two forms to be equivalent to
APC1338, the truncated protein in SW480 cells. Henceforth, we
will use APC-A, APC-B, APC-C, APC-D, APC-E and APC-F to
refer to the proteins in Classes A (e.g., full-length APC), B (e.g.,
APC1338), C, D, E and F (Fig. 3).
Using the model, we investigated the effects of transfection of
SW480 cells with APC-A through APC-F. In the model, the
endogeneous concentration of APC1338 in an SW480 cell is set at
100 nM. Similarly, the endogeneous concentration of full-length
APC in a normal cell is set at 100 nM (Table 1). Because
APC1338 does not contain the third 20-aa repeat, nor SAMP
repeats, Axin interactions associated with these sites (Fig. 2) are
absent in an SW480 cell. In contrast, in a normal cell, all

Figure 2. Site-specific details of the proteins and interactions
considered in the model. Proteins, interactions, and the functional
components that mediate interactions are represented according to the
conventions of Chylek et al. [42]. The numbering of arrows is the same
as in Fig. 1. The double-arrowed lines represent reversible binding
interactions. The lines ending with an open circle represent enzymesubstrate relationships and point to sites of phosphorylation. In the
model, b{catenin sites Ser-33, Ser-37, and Thr-41, which are GSK{3b
substrates, are lumped together as a single site labeled S33/37.
b{catenin site Ser-45, which is a CK1a substrate, is labeled S45. In the
model, the seven 20-aa repeats of APC are lumped into two distinct
sites labeled 1 and 3. For further information about the model, see
Materials and Methods. A complete and executable specification of the
model is provided in the Supporting Information as a plain-text
BioNetGen input file (Text S2). Note that there is a correspondence
between the arrows shown here and the rules of the model (Text S1).
Model parameter values are summarized in Table 1.
doi:10.1371/journal.pcbi.1003217.g002

co-confined to a small subvolume of the cytoplasm. An
intracomplex reaction can be marked by a high apparent affinity
because of the high local concentrations of the tethered binding
partners [47]. In the model, these reactions lead to complex
stabilization. We account for the high local concentration effect on
an intracomplex reaction by multiplying the corresponding
forward rate constant by an enhancement factor x. For instance,
if b{catenin and APC are already connected via Axin, then the
effective forward rate constant for the reaction represented by
Arrow 1 would be xkf , where kf is the intrinsic forward rate
constant when the proteins are not tethered together.
It should be noted that in the model b{catenin and APC can
form a binary complex held together by two-point attachment i.e.,
b{catenin and APC can be held together through simultaneous
PLOS Computational Biology | www.ploscompbiol.org
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Table 1. Model parameter values1.

Parameters

Comments
4

BCATtot = 35 nM (1.1610 copies/cell)

b–catenin concentration [53,59]

APCtot = 100 nM (3.26104 copies/cell)

APC concentration [53,59]

AXINtot = 10 nM (3.26103 copies/cell)

Axin concentration [59]

GSKtot = 100 nM (3.26104 copies/cell)

GSK–3b concentration [53,59]

CKl1atot = 100 nM (3.26104copies/cell)

CK1a concentration (assumed)

b–catenin ARM repeats 5–9 binding to the APC 15-aa repeat region
KD1,bap = 273 nM

Equilibrium dissociation constant [43]
Dissociation rate constant2

{1

kr1,bap ~KD1,bap |kf 1,bap ~0:273 s

b–catenin ARM repeats 3 and 4 binding to the phosphorylated APC 20-aa repeat
KD2,bap ~1:5 nM

Equilibrium dissociation constant [25]

kr2,bap ~KD2,bap |kf 2,bap ~0:0015 s{1

Dissociation rate constant2

b–catenin ARM repeats 3 and 4 binding to the phosphorylated APC1338 20-aa repeat
KD3,bap ~85 nM

Equilibrium dissociation constant [25]

kr3,bap ~KD3,bap |kf 3,bap ~0:085 s{1

Dissociation rate constant2

b–catenin ARM repeats 3 and 4 binding to Axin
KD,ba ~227 nM

Equilibrium dissociation constant [43]

kr,ba ~KD,ba |kf ,ba ~0:227 s

Dissociation rate constant2

{1

Axin binding to the APC SAMP repeats
KD,apa ~100 nM

Equilibrium dissociation constant (assumed)

kr,apa ~KD,apa |kf ,apa ~0:1 s{1

Dissociation rate constant2

GSK–3b binding to Axin
KD,ga ~65 nM

Equilibrium dissociation constant [68]

kr,ga ~KD,ga |kf ,ga ~0:065 s{1

Dissociation rate constant2

CK1a binding to Axin
KD,ca ~100 nM

Equilibrium dissociation constant (assumed)
Dissociation rate constant2

{1

kr,ca ~KD,ca |kf ,ca ~0:1 s

b–catenin phosphorylation and dephosphorylation (at both S33/S37 and S45 sites)
kp,b ~0:05 s{1

b–catenin phosphorylation rate constant

k{p,b ~0:0012 s{1

b–catenin dephosphorylation rate constant3

APC/APC1338 phosphorylation and dephosphorylation at the 20-aa repeat region (site 1 or 3)
kp ~0:05 s{1

APC phosphorylation rate constant4

k{p ~0:05 s{1

APC dephosphorylation rate constant4

b–catenin synthesis and degradation
Slow degradation rate constant4

kd,b1 ~4:28|10{5 s{1

Fast degradation rate constant4

{3 {1

kd,b2 ~4:28|10

s

Synthesis rate constant4

ks,b ~0:013|10{3 nM s{1 (4.0 molecules/s)
Enhancement factor
x = 104 nM

Enhancement factor for intracomplex binding4

1

Unit conversions are based on a cell cytoplasmic volume of 10{12 L [59].
For each binding reaction, the association rate constant (kf ) is assumed to be 10{3 nM{1 s{1 .
3
The half-life t1=2 of b{catenin phosphorylation is approximately 10 min [74].
4
The selected parameter values allow the model to reproduce a number of experimental observations, including 1) the steady-state b{catenin level, 2) the half-lives of
b{catenin and S33/S37-mutated b{catenin (Fig. S1), and 3) the kinetics of dephosphorylation of b{catenin at S33/S37 and S45 upon treatment with LiCl (Fig. S2).
See Materials and Methods for more details.
doi:10.1371/journal.pcbi.1003217.t001
2

interactions considered in the model are active, except for the lowaffinity interaction between APC and b{catenin involving the
phosphorylated first 20-aa repeat of APC and ARM repeats 3 and
4 of b{catenin. This low-affinity interaction is omitted when
considering a normal cell as a simplification (see Materials and

PLOS Computational Biology | www.ploscompbiol.org

Methods). In the model, when a representative of one of the six
classes of APC is introduced into an SW480 cell, any novel
interactions associated with the functional components of the
transfected protein become active. For example, when APC-A is
introduced, interactions associated with the third 20-aa repeat and
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Figure 3. Summary of APC constructs considered in simulated transfections and in the experimental study of Munemitsu et al. [31].
The 12 constructs used by Munemitsu et al. [31] are divided into six classes based on their structures. Proteins within the same class are functionally
equivalent according to our model. A representative of Class A (APC-A) contains all three protein binding sites considered in the model for full-length
APC. This class is regarded as equivalent to full-length APC. A representative of Class B (APC-B) contains 15-aa repeats and the first 20-aa repeat. This
class is regarded as equivalent to APC1338, the truncated form of APC found in SW480 cells. A representative of Class C (APC-C) corresponds to a
fragment that contains only the 15-aa repeats. A representative of Class D (APC-D) corresponds to a fragment that contains only the first 20-aa repeat.
A representative of Class E (APC-E) corresponds to a fragment that contains the 20-aa and SAMP repeats. A representative of Class F (APC-F)
corresponds to a nonfunctional fragment that contains none of the three APC sites included in the model.
doi:10.1371/journal.pcbi.1003217.g003

results in Fig. 4 were obtained without adjustment or fitting of
parameter values.

the SAMP repeats (Fig. 2) become active. These interactions are
normally missing in an SW480 cell. We assume that simulated
transfections each introduce 100 nM of new protein into a cell.
Thus, simulated transfection of SW480 with a particular form of
APC implies that the cell contains 100 nM of a protein
belonging to that form in addition to the 100 nM of the
endogeneous form of APC (APC1338). (We systematically
investigate how behavior depends on the amount of transfected
protein below.)
In Fig. 4, we compare the model-predicted changes in
b{catenin levels in SW480 cells after simulated transfection of
different forms of APC against the findings of Munemitsu et al.
[31] (Fig. 4). The model is able to recapitulate the qualitative
increase or decrease in b{catenin level observed after transfection of each class of protein. Consistent with the findings of
Munemitsu et al. [31], the model predicts that only transfection of
APC-A and APC-E leads to a decrease in b{catenin level,
whereas the other four classes of APC have the opposite or no
effect on b{catenin level (Fig. 4) [31]. It should be noted that the
PLOS Computational Biology | www.ploscompbiol.org

Role of full-length APC in b–catenin degradation
The results of Munemitsu et al. [31] suggest that exogeneous
full-length APC downregulates b{catenin by promoting
b{catenin degradation in SW480 cells. Similar results for
SW480 cells have been obtained in other studies [33,34].
However, transfection of different cell types have yielded different
results [33]. Using our model, we investigated whether overexpression of APC can generally be expected to increase the rate of
b{catenin degradation in all cell types, or if the effect may be
specific to SW480 cells only (Fig. 5).
Fig. 5A shows the model-predicted b{catenin level in a normal
cell as a function of APC level. A normal cell in the model is taken
to have endogeneous full-length APC at a cytosolic concentration
of 100 nM (Table 1). Fig. 5A illustrates the predicted effects of
added APC. Fig. 5A shows that increased abundance of APC does
not promote b{catenin degradation, rather it has a concentra7
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Figure 4. Comparison of simulated and observed effects of transfection of SW480 cells with APC constructs. Relative b{catenin levels
in SW480 cells in response to transfection with the APC constructs of Fig. 3 are shown. The gray bars, which correspond to the left y{axis, represent
experimental data from Munemitsu et al. [31]. The black bars, which correspond to the right y{axis, represent model predictions. The predicted
concentrations (black bars) are each divided by the concentration of b{catenin in a normal cell (35 nM, Table 1). For all APC constructs, the same
transfection efficiency is assumed. We take a transfected cell to contain 100 nM of added protein. The predicted results therefore represent the
effects of 100 nM of a construct in addition to 100 nM of endogeneous APC1338. The simulation results shown here were obtained using BioNetGen
input files provided in the Supporting Information: Text S3 was used for the APC-B and APC-F cases, Text S4 was used for the APC-A case, Text S5 was
used for the APC-C case, Text S6 was used for the APC-D case, and Text S7 was used for the APC-E case.
doi:10.1371/journal.pcbi.1003217.g004

tion-dependent positive effect on b{catenin level in normal cells,
in contrast to the effect in SW480 cells (Fig. 4). The effects of
exogenous full-length APC at different concentrations in SW480
cells are considered in Fig. 5B, which shows the model-predicted
b{catenin level in SW480 cells as a function of full-length APC
level. An SW480 cell is taken to have endogeneous APC1338 at a
cytosolic concentration of 100 nM (Table 1). The predicted effect
of added full-length APC is a significant decrease in b{catenin
level in SW480 cells over a wide range of exogeneous full-length
APC expression levels (Fig. 5B). This finding is consistent with the
effects of transient expression of full-length APC in SW480 cells
[31] and to some extent also with stable expression of full-length
APC in SW480 cells [34].

The only difference between APC-B and APC-C is that the
former form of APC contains the first 20-aa repeat, whereas the
latter form does not. This distinction leads to APC-B and APC-C
having opposite effects on b{catenin level in SW480 cells (cf.
Figs. 6A and 6B). APC-D contains the first 20-aa repeat but no
other functional components of APC that are able to interact with
b{catenin or Axin. Therefore, APC-D cannot interact with
b{catenin because of the consequent absence of phosphorylation
of the 20-aa repeat. The 20-aa repeat in APC-D is never
phosphorylated because the unphosphorylated protein is unable to
interact with Axin. Thus, APC-D has no effect on b{catenin
level (Fig. 6C). APC-E entails all structural features of APC-B, but
in addition it contains SAMP repeats, which mediate Axin binding
(Fig. 2). Because of this distinctive feature, the model predicts that
APC-E behaves differently from APC1338 and produces reduced
b{catenin levels at intermediate concentrations of APC-E similar
to the predicted effects of full-length APC (Fig. 5B). These results
indicate that the absence of SAMP repeats in APC1338 may have
an important role in APC1338-mediated increases of b{catenin
levels in cancer cells.

Concentration-dependent effects of truncated forms of
APC in SW480 cells
In Fig. 4, we assumed a fixed amount (100 nM) of exogeneous
expression for all six classes of APC. However, the results in Fig. 4
could depend on APC concentration, as seen for APC-A (Fig. 5).
Therefore, we investigated the predicted concentration-dependent
effects of APC-B, -C, -D and -E on b{catenin levels in SW480
cells (Fig. 6). For APC-A, such effects have already been discussed
(Fig. 5B). We do not consider APC-F because in our model it
represents a non-functional form of APC with no binding sites.
The simulation results in Fig. 6 illustrate the concentrationdependent effects of APC-B, -C, -D and -E. As seen in Fig. 6A,
added APC-B (e.g., APC1338) increases b{catenin level over the
entire concentration range considered. The level of b{catenin
doubles as the amount of exogeneous APC1338 approaches a 10fold higher amount of endogeneous APC1338 (Fig. 6A). Unlike
APC-B, the other three proteins do not increase b{catenin level
over the entire concentration range. APC-C reduces b{catenin
level at relatively high concentrations (Fig. 6B), APC-D does not
alter b{catenin level at any concentration (Fig. 6C), and APC-E
reduces b{catenin level over a range of intermediate concentrations in a manner similar to full-length APC (cf. Fig. 6D and
Fig. 5B).
PLOS Computational Biology | www.ploscompbiol.org

Phosphorylation-dependent competition between
APC1338 and Axin for binding to b–catenin
The analysis of Fig. 6 indicated that APC-B (e.g., APC1338)
and APC-C have opposite effects on b{catenin level because
APC-B contains a 20-aa repeat that APC-C does not. In Fig. 7,
we analyze the effects of phosphorylation of the 20-aa repeat in
APC-B on b{catenin levels in SW480 cells. Recall that
phosphorylation of the 20-aa repeat in APC is mediated by
CK1E and GSK{3b [30,45] and that phosphorylation of this
site is necessary for direct interaction of APC with b{catenin
[22,25].
The simulation results shown in Fig. 7A indicate that
phosphorylation of the 20-aa repeat is needed for APC-B/
APC1338-mediated stabilization of b{catenin. In the figure, the
solid line corresponds to default rate constants for phosphorylation
and dephosphorylation of APC in the model (Table 1). For these
8
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Figure 5. Concentration-dependent effects of full-length APC on b{catenin. (A) b{catenin level in a normal cell is shown as a function of
APC concentration. The x{axis represents the relative amount of APC introduced exogeneously with respect to the endogeneously present 100 nM
of full-length APC in a normal cell. The y{axis represents the level of b{catenin relative to its nominal level in a normal cell (Table 1). (B) b{catenin
level in an SW480 cell is shown as a function of APC concentration. The x{axis represents the amount of APC introduced exogeneously relative to
the endogeneously present 100 nM of APC1338 in an SW480 cell. The y{axis represents the level of b{catenin relative to its nominal level in a
normal cell, as in panel A. The simulation results shown here were obtained using BioNetGen input files provided in the Supporting Information: Text
S2 was used for panel A and Text S4 was used for panel B.
doi:10.1371/journal.pcbi.1003217.g005

of Fig. 7B show that phosphorylation of APC1338 inhibits
interaction of b{catenin with Axin.

parameter values, the 20-aa repeat is nearly always phosphorylated. This case can be viewed as the extreme opposite of the case
where the 20-aa repeat is deleted and therefore never present in
phosphorylated form. When the 20-aa repeat is deleted, APC-B
becomes equivalent to APC-C and downregulates b{catenin in a
similar manner (cf. Fig. 7A and Fig. 6C).
Phosphorylated APC1338 binds to ARM repeats 3 and 4 in
b{catenin, which is also a binding site for Axin (Fig. 2). Thus,
phosphorylated APC1338 competes with Axin for binding to
b{catenin and can inhibit phosphorylation of b{catenin by
sequestering b{catenin away from Axin-associated kinases.
Fig. 7B illustrates the predicted effect of APC1338 phosphorylation on association of b{catenin and Axin. The simulation results
PLOS Computational Biology | www.ploscompbiol.org

Mechanism of b–catenin upregulation by APC1338
The results of Fig. 7 suggest that competition between APC1338
and Axin for b{catenin binding upregulates b{catenin levels in
SW480 cells. These results however do not explain how APC1338
and APC regulate b{catenin differentially. Differential regulation
is somewhat paradoxical because both proteins have phosphorylation sites in the 20-aa repeat region, which mediates b{catenin
binding. The distinction between APC and APC1338 can be
attributed to the absence of SAMP repeats in APC1338, as
explained fully below. In short, APC1338 sequesters b{catenin
9
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Figure 6. Concentration-dependent effects of APC constructs in SW480 cells. Predicted b{catenin level is shown as a function of
expression level for APC-B, -C, -D, and -E. In each panel, the x{axis represents the amount of expression relative to the endogeneous level of
APC1338 (100 nM). The y{axis represents the b{catenin level relative to the nominal level in a normal cell (35 nM, Table 1). Thus, a value of 1 on
the x{axis corresponds to a concentration of 100 nM of transfected protein, and a value of 1 on the y{axis corresponds to a concentration of
35 nM of b{catenin. The simulation results shown here were obtained using BioNetGen input files provided in the Supporting Information: Text S3
was used for panel A, Text S5 was used for panel B, Text S6 was used for panel C, and Text S7 was used for panel D.
doi:10.1371/journal.pcbi.1003217.g006

b{catenin association with Axin, leading to less degradation. A
corollary of this finding is that increased expression of Axin would
be expected to increase the degradation of b{catenin, which has
been observed [36,51,52].

away from Axin, whereas APC fails to do so (Fig. 8). The
sequestration effect arises because APC1338, lacking SAMP
repeats, cannot mediate indirect association of b{catenin with
Axin. We note that the bell-shaped curve in Fig. 8B represents a
characteristic scaffold effect [49,50]. Here, the scaffold is APC and
the scaffold ligands are Axin and b{catenin.
In normal cells, b{catenin can associate with Axin in two
ways: 1) direct binding via ARM repeats 3 and 4 in b{catenin
(Arrow 3; Fig. 2), and 2) indirect binding via APC, with APC
acting as a linker between b{catenin and Axin (Arrows 2 and 4;
Fig. 2). As in an SW480 cell, the direct interaction in a normal cell
is also inhibited by phosphorylation of the 20-aa repeat region in
APC because of competition between phosphorylated APC and
Axin for binding to ARM repeats 3 and 4 in b{catenin.
Nonetheless, in a normal cell, the indirect interaction still enables
b{catenin to colocalize with Axin via APC [30], thus allowing
phosphorylation of b{catenin to occur via Axin-associated
kinases, which leads to degradation of b{catenin. In contrast,
in SW480 cells, b{catenin can associate with Axin only through
direct interaction. The indirect interaction does not occur because
APC1338 lacks the SAMP repeats necessary for Axin binding.
Thus, in SW480 cells, APC1338 phosphorylation effectively blocks
PLOS Computational Biology | www.ploscompbiol.org

Effect of stability of the core destruction complex on b–
catenin level
The stability of the destruction complex can be perturbed
(decreased) by preventing APC, Axin, and b{catenin from
forming a closed/cyclic ternary complex. The cyclic complex,
which we assume can form in normal cells, cannot form in SW480
cells as a result of APC truncation. Formation of the cyclic ternary
complex can be prevented not only by truncation of APC but also
by other mutations. Any mutation affecting one of the three
protein-protein interfaces of the ternary complex would prevent
closure of the cyclic structure. Using our model, we simulated
inhibition of formation of the cyclic structure by systematically
blocking each of the three protein-protein interfaces of the closed/
cyclic ternary complex, and we determined the resulting effect on
b{catenin level. As seen in Fig. 9, blocking the contact between
APC and b{catenin or b{catenin and Axin did not change
10
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Figure 7. APC1338 phosphorylation and its competition with Axin for b{catenin. (A) b{catenin level is shown at different levels of
APC1338 phosphorylation. Phosphorylation of APC1338 at the first 20-aa repeat is modulated by changing the values of the phosphorylation and
dephosphorylation rate constants kp and k{p . In the figure, the ratio, kp =k{p ~1 corresponds to the default values of kp and k{p in the model, which
are taken to be the same (Table 1). The case where kp =k{p ?? represents an extreme, where the 20-aa repeat always remains phosphorylated. The
case where kp =k{p ~0 represents the opposite extreme, where APC1338 never becomes phosphorylated. (B) Competition effects on
b{catenin{Axin binding arising from APC1338 phosphorylation. The y{axis represents the fraction of Axin in complex with b{catenin. The
patterns of the lines represent different phosphorylation and dephosphorylation rate constants, as labeled in panel A. The simulation results shown
here were obtained using Text S3, a BioNetGen input file provided in the Supporting Information.
doi:10.1371/journal.pcbi.1003217.g007

b{catenin level, indicating that the cyclic structure is unimportant for regulation of b{catenin level. Only blocking of the
interface between APC and Axin (by removal of SAMP repeats) is
predicted to upregulate b{catenin level. However, as established
above, this behavior arises for reasons other than destablilization
of the cyclic ternary complex of APC, Axin, and b{catenin.
Thus, our model indicates that destabilization of this complex
(through ablation of cyclization) is not an important effect of APC
truncation.

illustrated in Figs. 1 and 2, incorporates site-specific mechanistic
details about the destruction complex, which comprises a number
of signaling proteins. In colorectal cancer cells (e.g., SW480 cells),
the interactions of these proteins are altered by truncation of APC.
We have used our model to study the function of APC and the
effects of its truncation on b{catenin phosphorylation and
phosphorylation-dependent degradation. We caution that our
results pertain to only the function of APC within an idealized
destruction complex and furthermore that we considered the
interactions of particular (multifunctional) proteins in isolation
from most of their binding partners. Thus, within the context of a
cell, the functional effects of APC or truncated APC overexpression could potentially be very different from what our model
predicts. Nevertheless, the model is qualitatively consistent with
the observed effects of transient expression of various recombinant

Discussion
In this study, we have modeled b{catenin regulation by the
destruction complex in normal and colorectal cancer cells, which
express full-length and truncated APC, respectively. Our model,
PLOS Computational Biology | www.ploscompbiol.org
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Figure 8. Sequestration of b{catenin away from Axin by APC1338. (A) Predicted amount of b{catenin associated either directly or indirectly
with Axin is shown as a function of APC1338 concentration in the background of an SW480 cell. The horizontal axis indicates the amount of APC1338
divided by the nominal amount of APC1338 in an SW480 cell (100 nM). The vertical axis indicates the amount of Axin-associated b{catenin divided
by the total amount of b{catenin at steady state, which is a function of APC1338 concentration. (B) Predicted amount of b{catenin associated
either directly or indirectly with Axin is shown as a function of full-length APC concentration in the background of a normal cell. The horizontal axis
indicates the amount of full-length APC divided by the nominal amount of full-length APC in a normal cell (100 nM). The vertical axis indicates the
amount of Axin-associated b{catenin divided by the total amount of b{catenin at steady state, which is a function of full-length APC concentration.
(C) Predicted amount of b{catenin associated directly with APC1338 as a function of relative APC1338 concentration. (D) Predicted amount of
b{catenin associated directly with full-length APC as a function of relative full-length APC concentration. All results shown were obtained using the
parameter values of Table 1, except as indicated. The following BioNetGen input files were used to obtain simulation results: Text S3 was used for
panels A and C and Text S2 was used for panels B and D.
doi:10.1371/journal.pcbi.1003217.g008

forms of APC in SW480 cells [31] (Fig. 4). Stronger, less
ambiguous tests of model predictions in the future would ideally
be performed using an in vitro reconstituted or cell-free system [53]
to eliminate the uncertainties and complexities of the cellular
milieu.
Our analyses indicate that whilst the expression of full-length
APC in SW480 cells can be expected to increase degradation of
b{catenin, APC overexpression in normal cells may decrease
b{catenin degradation or have no effect. We show that
phosphorylation of the first 20-aa repeat in truncated APC,
together with the absence of the SAMP repeats, is crucial for the
effect of APC1338 on b{catenin levels in SW480 cells (Figs. 7
and 8). We suggest that phosphorylated APC1338 sequesters
b{catenin from Axin, thus blocking b{catenin phosphorylation
by Axin-bound kinases, viz. CK1a and GSK{3b. In contrast,
phosphorylation of full-length APC, because of its SAMP repeats,
which provide an indirect means for interaction between Axin and
b{catenin, does not block b{catenin association with Axin and
PLOS Computational Biology | www.ploscompbiol.org

Axin-bound kinases, except at significantly higher levels of
expression (cf. panels A and B in Fig. 8).
Several experimental studies have detected competition between phosphorylated full-length APC and Axin for b{catenin
binding [24,30,54,55], although the effect of such competition on
b{catenin levels has not been previously characterized.
Our results suggest that APC1338, similar to full-length APC,
can efficiently mediate competition with Axin for b{catenin
binding, even though it lacks the third 20-aa repeat (Fig. 3), the
high-affinity b{catenin binding site in full-length APC. In the
model, APC1338 associates with b{catenin with sufficient
strength to displace Axin because of two-point attachment via its
15-aa and phosphorylated 20-aa repeat sites (i.e., because of the
combined action of the interactions represented by Arrows 1 and 2
in Figs. 1 and 2). The single-site KD ’s for the interactions mediated
by these sites are &273 and 80 nM, respectively [25,43]. The
affinities are comparable to the affinity of Axin for b{catenin
ARM repeats 3 and 4 (KD ~227 nM [43]). However, if two-point
12
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Figure 9. Effects of simulated perturbations of the putative closed/cyclic core destruction complex. Three cases are considered, as
indicated in the descriptions of Text S8, S9, S10 (Supporting Information). Each of the three protein-protein interfaces, APC{b{catenin (Text S8),
b{catenin{Axin (Text S9), and APC-Axin (Text S10), is ablated such that a closed/cylic structure cannot form. The relative b{catenin level in each
case is compared with the nominal b{catenin level in a normal cell.
doi:10.1371/journal.pcbi.1003217.g009

attachment is possible, as we have postulated in our model, then
there is an avidity effect. This effect has been studied in other
systems [56–58] and may confer on phosphorylated APC1338 a
competitive advantage, allowing it to outcompete Axin for
b{catenin.
A critically important feature of our model is a greater
abundance of APC than Axin (Table 1). According to our model,
as discussed above, truncated APC in SW480 cells acts as a
diversion sink that sequesters b{catenin away from Axin. This
diversion-sink mechanism cannot be operative if Axin is more
abundant than APC. Recent measurements of APC and Axin in
SW480 cells indicate that the total amounts of Axin and APC are
comparable [59]. At first, these results might seem to contradict
the model presented here, which takes APC to be 10-fold more
abundant than Axin. However, Axin is not homogeneously
distributed in a cell. Much of the Axin in a cell is found in
cytoplasmic puncta [35,36]. Thus, only a fraction of total Axin
may be available in a form capable of joining a destruction
complex having the composition and structure considered here. A
more complicated model than that presented here would be
required to account for subcellular compartmentalization of APC,
Axin and b{catenin, which clearly play an important role in
Wnt=b{catenin signaling [2,3]. Such an effort is beyond the
intended scope of our study.
The role of colocalization of signaling proteins within the
destruction complex is not completely understood. In our model,
we assumed that the core of the destruction complex, formed by
mutual interactions of APC, Axin, and b{catenin, has a closed/
cyclic structure (as depicted in the cartoon diagram at the far left of
Fig. 9). Within this cyclic structure, there are three protein-protein
interfaces, and each of the three interfaces involves interaction
between two adjacent proteins, which are connected indirectly via
the third protein. Therefore, the binding sites at each interface are
confined together in a volume that is small relative to the total
volume of the cytoplasm and the local concentrations of tethered
PLOS Computational Biology | www.ploscompbiol.org

binding partners are high. Such high local concentrations can
confer on a cyclic structure more stablity than a linear structure of
the same composition [60]. It has been assumed that the
destruction complex provides a stable platform for phosphorylation of b{catenin by the Axin-recruited kinases GSK{3b and
CK1a. However, according to our analyses, stability of the core
destruction complex (i.e., the cyclic ternary complex of APC, Axin
and b{catenin) is not important for efficient degradation of
b{catenin. By systematically simulating ablation of each possible
contact between b{catenin, APC, and Axin, we demonstrate that
stability of the complex has little if any influence on b{catenin
degradation (Fig. 9). (Note that the bar at the far right of Fig. 9 is
explained by the diversion-sink mechanism.) We caution that, in
the model, stability of the cyclic structure is also determined by
factors other than the local concentration effect. Degradation of
b{catenin in a core complex can terminate its cyclic structure,
leaving behind a complex of APC and Axin only. In addition,
phosphorylated APC can disrupt the cyclic structure by breaking
the b{catenin-Axin interface through competitive binding and
sequestering of b{catenin away from the complex.
Questions may arise as to what other roles APC plays besides
destruction complex-mediated regulation of b{catenin because
our model indicates that elevated expression of APC in a normal
cell does not have a positive effect on b{catenin degradation
(Fig. 5A), i.e., an increase in APC abundance is not predicted to
cause a decrease in b{catenin level. A variety of other potential
functions of APC have been suggested. Phosphorylated APC has
been implicated in subcellular localization and nuclear shuttling of
b{catenin [32,61–63], and high-affinity binding of phosphorylated APC with b{catenin has been suggested to disrupt
b{catenin interaction with other binding partners, such as Ecadherin and the Tcf and Lef family transcription factors [24]. It
has been shown that APC competes with E-cadherin for binding
to the ARM repeat region of b{catenin [64]. Indeed, the main
effect of stable expression of full-length APC in SW480 cells is not
13
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a reduction of b{catenin level (although there is an approximate
2-fold reduction in the total amount of b{catenin), but rather a
redistribution of b{catenin from the nuclear and cytosolic
compartments to the plasma membrane [34]. Transient expression of APC (at higher levels) causes a more dramatic reduction in
the level of b{catenin [31,34]. In future work, it would be
interesting to investigate how E-cadherin may regulate b{catenin
and vice versa [3].
Our study identifies CK1E as a potential target for therapeutic
intervention in colorectal cancer. Inhibiting CK1E is expected to
reverse the effect of truncation of APC in SW480 cells. According
to the model, phosphorylation of APC1338 at the first 20-aa
repeat plays a key role in upregulating b{catenin in cancer cells
(Fig. 7). Therefore, inhibition of phosphorylation of APC at this
site might be an effective way to normalize b{catenin levels in
cancer cells. Phosphorylation of APC requires the combined
action of two kinases, CK1E and GSK{3b [30]. Therefore,
blocking of either kinase is predicted to reduce APC phosphorylation, as shown by Ha et al. [30]. Because GSK{3b is a
common kinase for both b{catenin and APC (Fig. 1) and its
inhibition would stabilize b{catenin, only CK1E is a potential
target. We note that targeting of CK1E should be feasible in
preclinical studies, as pharamacological kinase inhibitors specific
to CK1E are available [65–67].
In this study, we used a detailed mechanistic modeling approach
based on the principles of chemical kinetics to investigate
regulation of b{catenin phosphorylation and degradation by
full-length and truncated APC. In a previous study, Lee et al. [53]
developed a related model to investigate regulation of b{catenin
by Wnt stimulation. However, this model does not consider
truncated APC. Another notable difference is that the model of
Lee et al. [53] is an ordinary differential equation (ODE)-based
model, wherein molecules and complexes of signaling proteins are
treated as reactive chemical species, which must be enumerated
along with all possible reactions to obtain an executable model. In
contrast, because of the goals of our study, we developed our
model using the rule-based modeling approach [37–40]. With this
approach, local rules are used to represent protein-protein
interactions, which are assumed to be modular. Assumptions of
modularity can greatly reduce the complexity of a model for
protein-protein interactions, and as a result, enable explicit
consideration of multiple functional components within proteins
(e.g., the multiple sites of phosphorylation in b{catenin). In our
model, the components of the proteins considered are the basic
reactive elements, i.e., we consider biochemical reactions, such as
reversible binding and phosphorylation, to occur at the level of
protein sites. This approach was critical for the goals of our study,
which included a characterization of the effects of loss of sites in
APC. Such effects, and biomolecular site dynamics in general, are
difficult to capture in an ODE model [40]. The study presented
here provides an example of how rule-based modeling, a fairly
new approach in biology, can be used to study biomolecular site
dynamics.
We focused on a part of the Wnt/b{catenin signaling pathway
that controls b{catenin degradation and expression level. Our
primary goal was to understand the differential regulation of
b{catenin in normal and cancer cells at steady state and in the
absence of Wnt signals, unlike in other modeling studies that have
focused on the dynamics of b{catenin regulation in response to a
Wnt ligand [20,53]. In future work, it would be interesting to
extend our model by connecting it to other components of the
Wnt/b{catenin signaling pathway and to further investigate the
dynamics of regulation of b{catenin.

PLOS Computational Biology | www.ploscompbiol.org

Materials and Methods
Parameter values
Model parameter values are listed in Table 1. Most of the
parameter values are based on previously reported estimates.
However, some parameter values were set to allow the model to
capture a set of observed system behaviors.
In the model, the concentration of b{catenin depends in part
on its rates of synthesis and degradation. As discussed below, we
set parameters for these and other processes considered in the
model such that the nominal, steady-state concentration of
b{catenin is 35 nM [53], which corresponds to 11,000 copies/
cell assuming a cytoplasmic volume of 10{12 L [59]. This
concentration is consistent with the concentration of b{catenin
measured in Xenopus egg extract [53]. It is also consistent with the
cytosolic (but not total) concentration of b{catenin measured in
HEK293T and MDCK cells, kidney epithelial cell lines, and in
Caco-2 cells [59], an intestinal cell line. We take both APC and
GSK{3b concentration to be 100 nM (31,540 copies/cell).
Concentrations of APC and GSK{3b have been measured to
be 100 nM and 50 nM, respectively, in Xenopus egg extract [53],
and measured concentrations of these proteins in mammalian cells
fall in the ranges of 4–34 nM and 10–120 nM, respectively [59].
We take CK1a concentration to be the same as GSK{3b,
100 nM. We assume Axin to be present at 10 nM (3,154 copy/
cell), which is consistent with recent measurements of Axin
abundance in mammalian cells; the Axin concentration measured
in mammalian cells ranges from 20 to 150 nM [59]. Lee et al. [53]
reported that Axin is present in Xenopus egg extract at a very low
concentration, in the range of 10 to 20 pM [53]. We rejected this
value, while accepting and using the qualitative observation of Lee
et al. [53] that Axin is less abundant than APC, because a
concentration of 20 pM corresponds to only six copies of Axin per
cell for a human epithelial cell, which as stated above is taken to
have a cytoplasmic volume of 10{12 L [59].
For association of any two proteins that are not already in a
complex together we assume the same forward rate constant (kf )
for all interactions: 10{3 nM{1 s{1 (Table 1). Each reverse rate
constant (kr ) is determined from the relation kr ~kf |KD , where
KD is the equilibrium dissociation constant for the reaction of
interest. Equilibrium dissociation constants are set at values
reported earlier in the literature, as indicated below.
In the model, the region in b{catenin containing ARM repeats
5–9 interacts with the 15-aa repeat region in APC (Arrow 1)
with KD1,bap ~273 nM (kr,bap ~0:273 s{1 ) [43]. The region in b{
catenin containing ARM repeats 3 and 4 interacts with the
phosphorylated 20-aa region in APC (Arrow 2) with an affinity
that depends on whether APC is full length or truncated
(APC1338). Phosphorylated full-length APC binds the
b{catenin ARM repeats 3 and 4 with KD2,bap ~1:5 nM
(kr2,bap ~1:5|10{3 s{1 ), whereas phosphorylated APC1338
binds with KD3,bap ~85 nM (kr3,bap ~0:085 s{1 ) [25]. We assume
that APC binds b{catenin via only a single 20-aa repeat, which is
consistent with binding of b{catenin at one 20-aa repeat
sterically hindering binding of additional copies of b{catenin at
other 20-aa repeats. When phosphorylated, the third 20-aa repeat
mediates binding with KD2,bap ~1:5 nM, whereas the other six 20aa repeats appear to bind with much lower affinites [25].
b{catenin binds the central region of Axin via ARM repeats 3
and 4 (Arrow 3) with KD,ba ~227 nM (kr,ba ~0:227 s{1 ) [43].
GSK{3b binds the Axin GID domain (Arrow 5) with KD,ga ~65
nM (kr ~0:065 s{1 ) [68]. We assume that APC and CK1a bind
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Axin (Arrow 4 and 6, respectively) with the same KD : KD,apa ~100
nM (kr,apa ~0:1 s{1 ) and KD,ca ~100 nM (kr,ca ~0:1 s{1 ).
In the model, b{catenin level is determined not only by
b{catenin synthesis and degradation rate constants, but also by
other parameters that affect the phosphorylation of b{catenin
and APC. These parameters include phosphorylation and
dephosphorylation rate constants and the enhancement factor x.
All of these parameters directly or indirectly determine the total
level of b{catenin. We selected values for these parameters,
which are given in Table 1, such that the model captures a set of
experimentally-observed system behaviors.
With the parameter values listed in Table 1, the model
reproduces a steady-state concentration of (cytosolic) b{catenin
of 35 nM, which as discussed above is consistent with some
measurements [53,59]. Furthermore, the model predicts the
effective half-life of b{catenin to be &30 min, and the half-life
of b{catenin mutated at S33/S37 to be &4:5 h, which is
consistent with the observations of Rubinfeld et al. [14] (Fig. S1).
The model also reproduces the experimentally-determined kinetics
of b{catenin dephosphorylation at distinct phosphorylation sites
in response to treatment with LiCl, an inhibitor of GSK{3b [12]
(Fig. S2). The consistency of the model with observed system
behaviors is further discussed in the Results section.
We note that the model is not entirely consistent with recent
measurements of APC, Axin, (cytosolic) b{catenin, and
GSK{3b concentrations in SW480 cells [59]. The model cannot
simultaneously reproduce these concentrations and observed
system behaviors. This could be because the measured concentrations do not reflect the subcellular concentrations relevant for
destruction complex function. Alternatively, our mechanistic
knowledge of destruction complex function could be incomplete.
We formulated our model to probe the limits of understanding of
destruction complex function. In setting parameter values, we put
an emphasis on selecting values that allow the model to reproduce
observed system behaviors, rather than measured system parameters (viz., protein concentrations). This approach is guided by
findings from computational analyses of model sloppiness, which
indicate that fitting tends to improve the accuracy of model
predictions more than parameter measurement [69].

an interaction that can take place between either unconnected
proteins or tethered proteins. Thus, there is a rule for each of these
two cases.

Simulation
The base model (Figs. 1 and 2) and each variant model was
simulated by submitting the corresponding model-specficiation file
to BioNetGen [39,70] for processing. Model-specification files are
provided in the Supporting Information (Text S2, S3, S4, S5, S6,
S7, S8, S9, S10); the format of these files is plain text. Simulation
protocols are included in each model-specification file. The
captions of figures indicate which model-specification files were
used in calculations. In all cases, the method used for simulation
was an indirect method, meaning that the rules of the model being
simulated were not used directly in the simulation procedure.
Rather, the rules were expanded (i.e., used to exhaustively
enumerate the distinct chemical species and individual chemical
reactions implied by the rules) by invoking the generate_
network function of BioNetGen to obtain a reaction network.
The corresponding system of ODEs describing the mass-action
kinetics of this network were then numerically integrated by
invoking the simulate_ode function of BioNetGen. BioNetGen
uses CVODE [72,73] for numerical integration of ODEs. For the
base model, the reaction network obtained by expansion of its
rules comprises 410 distinct chemical species. The size of this
network does not reflect the intrinsic complexity of the base model.
Rather, the intrinsic complexity of this model is reflected by the
number of its rules. The base model includes 29 rules. We used
scripts to systematically vary default parameter values specified in
BioNetGen input files to produce many of the figures shown in the
Results section. Parameter scans are enabled by a function
available within RuleBender [71].

Supporting Information
Figure S1 The model reproduces the half-lives of
b{catenin and b{catenin mutated at S33/S37. The model
predicts the half-life of b{catenin in a normal cell to be 30 min
(solid line) and the half-life of b{catenin mutated at the S33/S37
phosphorylation site to be 4.5 h (dashed line). These predicted
values are consistent with the measured values reported by
Rubinfeld et al. [14]. The figure illustrates model-predicted decay
of cellular b{catenin or b{catenin mutated at S33/S37 in a
simulated pulse-chase experiment [14]. The model was used to
simulate the pulse-chase experiments of Rubenfield et al. [14],
which were carried out to determine the half-lives of the proteins.
(EPS)

Model specification
We will refer to the model illustrated in Figs. 1 and 2 as the base
model. The base model corresponds to the case of a normal cell
with full-length APC. Variants of the base model correspond to
SW480 cells with APC1338, SW480 cells transfected with different
forms of APC, and other cases considered in this study (see below
for further details). The base model and each of its variants was
formulated using BNGL, a model-specification language [39].
Executable model-specification files are provided in the Supporting Information for the base model (Text S2) and its variants (Text
S3, S4, S5, S6, S7, S8, S9, S10). BNGL is compatible with
BioNetGen [39,70], a software tool for rule-based modeling, and a
number of other tools, such as RuleBender [71], an interface for
BioNetGen. In addition to parameter values and initial data, each
model-specification included molecule type definitions and rules.
Molecule type definitions delimit the functional components of
proteins and their possible phosphorylation states. The rules
characterize protein-protein interactions and other processes (viz.,
synthesis and degradation of b{catenin). The rules that
characterize protein-protein interactions can be subdivided into
10 sets, with one set for each arrow in Fig. 1 or 2. An arrow
corresponds to multiple rules if the interaction represented by the
rule can take place in multiple contexts and the context influences
the rate of reaction. For example, Arrow 3 in Fig. 1 or 2 represents
PLOS Computational Biology | www.ploscompbiol.org

Figure S2 The model reproduces the effects of LiCl
treatment on phosphorylation of cellular b{catenin. The
figure shows predicted and measured phosphorylation of
b{catenin at S45 and S33/S37 in response to LiCl treatment
of cells. The solid lines represent model predictions, and the points
represent experimental data of Liu et al. [12]. The solid line/filled
circles correspond to S45, and the dashed line/open circles
correspond to S33/S37. In the model, LiCl addition is simulated
by assuming a 20-fold decrease in kinase activity of GSK{3b (i.e.,
20-fold reduced rate of phosphorylation of the APC 20-aa repeats
and S33/S37 in b{catenin). The kinase activities of CK1a and
CK1E are assumed to be unaffected by LiCl treatment. Time t~0
represents the time of LiCl addition. The y{axis values represent
phosphorylation of S45 or S33/S37 relative to the steady-state
levels of phosphorylation of these sites in the absence of LiCl.
(EPS)
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Table S1 Local parameter sensitivity analysis. The

Thus, rules for APC1338 interactions are the same as rules for
APC-B interactions. In simulated transfections of APC-B, the
amount of added APC-B (taken to be equivalent to an increase in
endogenous APC1338) was systematically varied. Finally, we note
that this file was used for simulating the effect of varying the rate at
which the 20-aa repeat region in APC is phosphorylated. In these
simulations, the rate constant for APC phosphorylation (denoted
as kp in Table 1 and as kp in model-specification files) was
systematically varied.
(TXT)

steady-state level of b{catenin is insensitive to variations of
model parameter values, as assessed by local sensitivity coefficients.
(PDF)
Text S1 Model annotation wiki. This TiddlyWiki (tiddlywiki.com), which takes the form of a single HTML file, provides
extensive annotation of the molecule type definitions and rules that
comprise the base model, as well as discussion of various modeling
assumptions. The wiki can be viewed and navigated using a Web
browser. It contains links to relevant information available in
public online resources, including UniProt [75], OMIM [76], and
Pfam [77].
(TXT)

Text S4 BioNetGen input file for model variant 2. This
file specifies a model for an SW480 cell (i.e., a cell expressing
APC1338 endogenously) transfected with APC-A (M2 ). The
amount of added APC-A was systematically varied in simulations. Recall that APC-A includes full-length APC, APC 2 and
APC 4 (Fig. 3), which are taken to be functionally equivalent
because these forms of APC contain 15-aa repeats, all 20-aa
repeats, and SAMP repeats. In this model, separate rules are
specified for APC1338 and APC-A interactions. The rules
account for all of the APC interactions considered in models M0
and M1 .
(TXT)

Text S2 BioNetGen input file for model illustrated in
Figs. 1 and 2. This file, which can be processed by BioNetGen
(after changing the file name extension to .bngl), provides a
complete executable specification of the base model M0 , i.e., the
model for a normal cell with full-length APC. In this model, the
low-affinity interaction of b{catenin with the first (phosphorylated) 20-aa repeat in APC (Arrow 2 in Figs. 1 and 2) is omitted
for simplicity. This simplification does not prevent interaction of
b{catenin with phosphorylated APC, because a rule is included
for the (dominant) high-affinity interaction of b{catenin with
the third (phosphorylated) 20-aa repeat (Arrow 2 in Figs. 1 and
2). Note that the base model and all of its variants include rules
not only for the interactions illustrated in Figs. 1 and 2 but also
for synthesis and degradation of b{catenin as well as rules for
dephosphorylation of APC and b{catenin. We note that this
file can be viewed as specifying a model for a normal cell
transfected with APC-A (full-length APC, APC2 or APC 4)
(Fig. 3). All forms of APC-A are taken to be functionally
equivalent to full-length APC, because each form contains the
same functional components that are considered in the base
model for full-length APC (15-aa repeats, 20-aa repeats, and
SAMP repeats). In simulated transfections of APC-A, the
amount of added APC-A (taken to be equivalent to an increase
in full-length APC) was varied systematically. See the Simulation subsection in the Materials and Methods section for more
information.
(TXT)

Text S5 BioNetGen input file for model variant 3. This
file specifies a model for an SW480 cell transfected with APC-C
(M3 ). The amount of added APC-C was systematically varied in
simulations. Recall that APC-C includes APC 21 and APC 22
(Fig. 3), which are taken to be functionally equivalent because
both of these forms of APC contain 15-aa repeats while missing
all 20-aa repeats and the SAMP repeats. In this model, separate
rules are specified for APC1388 and APC-C interactions. The
only interaction in which APC-C can participate is the
constitutive interaction between APC and b{catenin (Arrow
1 in Figs. 1 and 2).
(TXT)

BioNetGen input file for model variant 4.
This file specifies a model for an SW480 cell transfected with
APC-D (M4 ). The amount of added APC-D was systematically
varied in simulations. Recall that APC-D includes only APC 23
(Fig. 3), which contains only the first 20-aa repeat. Although
APC-D contains a 20-aa repeat, APC-D cannot be phosphorylated because it lacks other components needed for association
with Axin. Thus, this model is essentially the same as model
M1 .
(TXT)
Text S6

Text S3 BioNetGen input file for model variant 1. This
file specifies the model for an SW480 cell with truncated APC
(APC1338). This model (M1 ) differs from M0 in that full-length
APC is replaced by APC1338, meaning that the rule for
interaction of Axin with the SAMP repeats in APC is removed
(Arrow 4 in Figs. 1 and 2) and the rule for high-affinity interaction
of b{catenin with the third (phosphorylated) 20-aa repeat is
replaced by a rule for the low-affinity interaction of b{catenin
with the first (phosphorylated) 20-aa repeat (Arrow 2 in Figs. 1 and
2). Other interactions involving APC remain the same. These
changes are intended to capture the effects of C-terminal
truncation of APC, which commonly and in the case of
APC1338 means a loss of the SAMP repeats and all but the first
20-aa repeat. We note that this file can also be viewed as specifying
a model for an SW480 cell transfected with APC-B or APC-F.
Recall that the APC-F class of proteins (APC 3, APC arm, and
APC 20) do not contain any of the functional components of fulllength APC considered in the model (Fig. 3). Thus, in the model,
APC-F does not participate in any interactions (i.e., there are no
rules that involve APC-F). Recall that APC-B includes APC 21
and APC 22 (Fig. 3), both of which are taken to be functionally
equivalent to APC1338 because these forms of APC, like
APC1338, each includes 15-aa repeats and the first 20-aa repeat.
PLOS Computational Biology | www.ploscompbiol.org

Text S7 BioNetGen input file for model variant 5. This
file specifies a model for an SW480 cell transfected with APC-E
(M5 ). The amount of added APC-E (or APC 25, Fig. 3) was
systematically varied in simulations. In this model, separate rules
are specified for APC1388 and APC-E interactions. APC-E
participates in the same interactions as APC1338 except for the
constitutive interaction between APC and b{catenin (Arrow 1 in
Figs. 1 and 2), which is mediated by the 15-aa repeats that are
missing in APC-E.
(TXT)
Text S8 BioNetGen input file for model variant 6. This
model (M6 ) is the same as M0 except that the association rate
constant for APC binding to b{catenin kf 1,bap (denoted as
kf1_bap in model-specification files) has been set to 0. Note that
kf 1,bap characterizes the interaction represented by Arrow 1 in
Figs. 1 and 2.
(TXT)
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Text S9 BioNetGen input file for model variant 7. This
model (M7 ) is the same as M0 except that the association rate
constant for Axin binding to b{catenin (denoted as kf ,ba in
Table 1 and as kf_ba in model-specification files) has been set to
0. Recall that Arrow 3 in Figs. 1 and 2 represents the interaction
between Axin and b{catenin.
(TXT)

Recall that Arrow 4 in Figs. 1 and 2 represents the interaction
between APC and Axin.
(TXT)
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